Kidiamix G Start (Valine, Acetylcysteine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine)

Kidiamix G Start, an amino acid solution used in parenteral nutrition, is indicated for:

• Neonatal parenteral nutrition: supports growth and protein synthesis in premature infants when enteral feeding is not feasible.
• Infant parenteral nutrition: provides essential amino acids for infants with gastrointestinal disorders or postoperative recovery.
• Severe malabsorption: supplies a complete amino acid profile to patients unable to absorb nutrients enterally.
• Preterm newborns with low birth weight: helps maintain nitrogen balance and promote tissue development.

• Kidiamix G Start delivers a balanced mixture of essential and non‑essential amino acids directly into the bloodstream. The amino acids serve as substrates for protein synthesis, replenish nitrogen stores, and support cellular metabolism. By bypassing the gastrointestinal tract, the solution provides immediate and adequate availability of building blocks required for tissue growth, repair, and immune function in neonates and infants who cannot receive enteral nutrition.

Kidiamix G Start may be associated with the following adverse reactions observed in clinical use.

Common Side Effects

• Hyperglycemia: elevated blood glucose levels during infusion.
• Electrolyte imbalance: changes in potassium, sodium or calcium concentrations.
• Phlebitis: inflammation at the infusion site.
• Metabolic acidosis: decreased blood pH due to amino acid metabolism.

Serious or Rare Side Effects

• Anaphylactic reaction: severe hypersensitivity requiring immediate medical intervention.
• Sepsis: risk of infection if sterility is compromised.
• Severe electrolyte disturbances: life‑threatening hyperkalemia or hypocalcemia.
• Renal failure: acute kidney injury in susceptible patients.

When using Kidiamix G Start, consider the following precautions to ensure safe administration.

• Renal function assessment: evaluate kidney performance before and during therapy.
• Electrolyte monitoring: regularly check serum potassium, sodium, calcium and phosphate levels.
• Infusion rate control: adjust speed according to patient tolerance and metabolic status.
• Aseptic technique: use sterile equipment and follow strict hygiene to prevent contamination.
• Hypersensitivity screening: avoid in patients with known allergy to any amino acid component.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G Start can interact with certain medications; awareness of these interactions helps prevent complications.

Major Interactions (Avoid)

• Calcium‑containing solutions: may precipitate with amino acids, causing line blockage.
• High‑dose potassium supplements: increase risk of hyperkalemia.
• Other parenteral nutrition admixtures: incompatibility may lead to precipitation or reduced efficacy.

Moderate Interactions (Monitor Closely)

• Diuretics: alter electrolyte balance, requiring closer monitoring.
• Insulin therapy: may affect glucose control during amino acid infusion.
• Anticoagulants: amino acid solutions can influence coagulation parameters.